NeoGenomics Reports Record Revenues of $20.7 Million on 40% Test Volume Growth and Expanding Gross Margins for the Second Quarter 2014
Press Release
Read More
NeoGenomics Expands Next Generation Sequencing Services and Offers 23 Different Profiles for Various Hematologic and Solid Cancers
Press Release
Read More
Molecular profiling in determining diagnosis and prognosis of "early" myelodysplastic syndrome
Literature
Read More
NeoGenomics Raises Guidance and Projects 30% Year-Over-Year Revenue Growth in Quarter 2, 2014
Press Release
Read More
A single slide multiplex assay for the evaluation of classical Hodgkin lymphoma.
Literature
Read More